600 Participants Needed

Attention Bias Modification for Depression

Cg
CG
Overseen ByChristopher G Beevers, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to test two different Attention Bias Modification (ABM) treatments for people with depression. Researchers will compare a gamified version of ABM, delivered via a mobile app, with traditional ABM and a sham (fake) version to determine which is more effective in reducing depressive symptoms. The study will also explore the mechanisms behind these treatments and the duration of their effects. Individuals who have experienced depression symptoms, are fluent in English, and have not recently changed their medication may be suitable candidates. Participants will complete surveys, eye-tracking tasks, and interviews. As an Early Phase 1 trial, this research focuses on understanding how these innovative treatments work in people, offering participants a chance to contribute to groundbreaking mental health research.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but you must not have changed your antidepressant medication or dosage in the past 12 weeks to be eligible.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Studies have shown that both game-like and traditional Attention Bias Modification (ABM) treatments are generally easy for people to handle. Research indicates that just one session of the game-like ABM can effectively lower anxiety and stress without major safety concerns. In studies with adults who have depression, traditional ABM has not shown significant side effects, suggesting it is also safe to use.

Since this study is in its early phase, it primarily focuses on assessing the safety and effectiveness of the treatments. Early-phase trials involve careful monitoring to ensure participant safety. Although specific reports of safety issues have not emerged in these studies, researchers are still gathering detailed safety information due to the trial's early stage. Participants can feel reassured that early-phase trials prioritize their safety.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about these treatments because they offer a fresh approach to tackling depression by targeting attention biases. Unlike standard treatments like antidepressants or cognitive behavioral therapy, these methods use Attention Bias Modification (ABM) to directly alter how people with depression focus on emotional cues. The gamified ABM stands out by using a mobile app to present happy and sad stimuli, training users to focus more on positive cues in a fun, engaging way. Meanwhile, the traditional ABM offers a web-based program that helps shift attention away from negative emotions, and the sham ABM serves as a control to test the effectiveness of these new methods. This innovative approach could potentially offer a quick, accessible tool to complement traditional therapies for depression.

What evidence suggests that this trial's treatments could be effective for depression?

Research has shown that Attention Bias Modification (ABM) can reduce depression symptoms by altering focus on negative thoughts. This trial will compare different ABM methods. Participants in one arm will use Gamified ABM, which employs a mobile app with interactive features and has shown promise in improving mood by changing negative thought patterns. Another arm will involve Traditional ABM, offered online, which has also been effective in reducing negative thinking and improving brain connections related to mood. Although the results are promising, improvements have been small and varied. Overall, researchers are actively studying ABM treatments for their potential to help with depression by retraining how the brain handles emotional information.13678

Who Is on the Research Team?

CG

Christopher G Beevers, PhD

Principal Investigator

UT Austin

Are You a Good Fit for This Trial?

This trial is for adults with symptoms of depression. Participants will be asked to fill out questionnaires, do eye-tracking tasks, and undergo interviews by clinicians. Details on specific inclusion or exclusion criteria are not provided.

Inclusion Criteria

My antidepressant medication and dose have been stable for the last 12 weeks.
Fluent in English
Provided informed consent
See 1 more

Exclusion Criteria

I have been diagnosed with bipolar or psychotic disorders.
I am currently taking opioids or corticosteroids.
I am currently undergoing psychotherapy.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either gamified, traditional, or sham ABM treatments for depression

4 weeks
Weekly sessions

Follow-up

Participants are monitored for the durability of ABM effects on depression symptoms

24 weeks
Monthly assessments

What Are the Treatments Tested in This Trial?

Interventions

  • Gamified Attention Bias Modification
  • Sham Attention Bias Modification
  • Traditional Attention Bias Modification
Trial Overview The study tests two types of Attention Bias Modification (ABM) treatments: a gamified version and the traditional one, against a sham (inactive) treatment. It aims to see which ABM method is more effective at improving depression symptoms and how long the effects last.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Gamified Attention Bias ModificationExperimental Treatment1 Intervention
Group II: Traditional Attention Bias ModificationActive Control1 Intervention
Group III: Sham Attention Bias ModificationPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Texas at Austin

Lead Sponsor

Trials
387
Recruited
86,100+

Arcade Therapeutics

Collaborator

Trials
1
Recruited
600+

Citations

beevers, christopher g - NIH RePORTERThis prior work demonstrates that active ABM engages and alters negative attention bias and there is a preliminary efficacy signal that ABM reduces depression.
Efficacy of traditional and gamified attention bias ...We hypothesize that gamified and traditional ABM will lead to significantly greater reductions in self-reported and interviewer-rated depression symptoms than ...
Confirmatory Efficacy Trial of Attention Bias Modification for ...The goal of this clinical trial is to compare the efficacy of two related, but different ABM (Attention Biased Modification) treatments for depression in adults ...
4.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/39725004/
Efficacy of traditional and gamified attention bias modification ...We hypothesize that gamified and traditional ABM will lead to significantly greater reductions in self-reported and interviewer-rated depression ...
Testing the Effectiveness of a Gamified Emotional Cognitive ...The results demonstrated that GCBM training positively changed the participants' responses to emotional faces compared with control condition.
Mental Health on the Go: Effects of a Gamified Attention Bias ...Results showed that a single session of gamified ABMT effectively reduces threat bias, subjective anxiety, and stress reactivity. ... These technologies are ...
Gamified Attention Bias Modification Training to Augment ...Augmenting cognitive–behavioral therapy (CBT) with attention bias modification training (ABMT) may maximize therapeutic benefit for anxiety ...
Gamified Web-Delivered Attentional Bias Modification ...Primary outcomes included self-reported and behavioral engagement, pain intensity, and pain interference. Secondary outcomes included anxiety, ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security